Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs Hilton Hotels Corporation Common Stock (HLT) Price & Performance

Amylx Pharmaceuticals IncTrade
Hilton Hotels Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Hilton Hotels Corporation Common Stock — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Hilton Hotels Corporation Common Stock trades at $318 (market cap $70.82B). The key difference: Hilton Hotels Corporation Common Stock is far larger — about 26.8× Amylx Pharmaceuticals Inc's market cap, and Hilton Hotels Corporation Common Stock pays a 0.19% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

AMLXHLT
Market Cap
$2.64B$70.82B
Sector
HealthConsumer Cyclical
52-Week High
$24.19$350.22
52-Week Low
$7.82$256.75
Enterprise Value
$2.39B$83.83B
Dividend Yield
0.19%

Returns comparison

Trailing returns across standard periods

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About Hilton Hotels Corporation Common Stock

Hilton Worldwide Holdings operates 1,074,791 rooms across its 18 brands addressing the midscale through luxury segments as of Dec. 31, 2021. Hampton and Hilton are the two largest brands by total room count at 28% and 21%, respectively, as of Dec. 31, 2021. Recent brands launched over the last few years include Home2, Curio, Canopy, Tru, and Tempo. Managed and franchised represent the vast majority of adjusted EBITDA, predominantly from the Americas regions.

Read more on HLT